Global Digital Genome Market 2021-2028

The publisher predicts that the global market for digital genome would witness a CAGR of 9.57% over the forecast period 2021-2028. It garnered $10061.6 million in 2020, and is estimated to generate net revenue of approximately $20902.1 million by 2028.

In recent years, the incidence of chronic diseases has amplified, in turn creating a huge burden on the healthcare system. This has majorly created the demand for the adoption of the digital genome technology. Further, support by the government in the form of funds for development in the field of genomics is also contributing to market growth.

However, there are certain risks associated with digital genomes, which act as hindrances in the process of growth. Also, the lack of skilled professionals in the field of genome technology is negatively impacting the market growth. On the positive side though, the advancements in technology and the growing awareness in developing economies are creating avenues for the growth of the studied market in the forthcoming years.

REGIONAL OUTLOOK

The global digital genome market encompasses the regions of North America, Latin America, Europe, the Asia-Pacific, and the Middle East and Africa.
North America dominates the global market at present, and is expected to continue its reign till the end of the forecasting period. This is attributable to the higher incidence rates of monogenic diseases in the region as well as the high adoption of advanced techniques in genomics. Also, the presence of well-established research institutes in the United States, with experts working continuously to further develop this technology, is aiding the growth of North America’s digital genome market.

COMPETITIVE OUTLOOK

The top companies that have been studied in this market include Thermofisher Scientific Inc, Regeneron Pharmaceuticals, Abbott Laboratories, Biomerieux SA, Oxford Nanopore Technologies Ltd, Pacific Bioscience, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc, Qiagen NV, Inscripta, F. Hoffmann-La Roche, Perkinelmer Inc, and Becton Dickinson and Company (BD).
Established in 2006, Thermofisher Scientific Inc is a multinational company operating in several domains. It has four business segments: Analytical Instruments, Laboratory Products & Services, Life Sciences Solutions, and Specialty Diagnostics. The company develops and delivers its products and solutions to hospitals, clinical diagnostic labs, government agencies, research institutions, universities, and pharmaceutical & biotech companies. With a presence in more than 50 countries, Thermofisher serves more than 400,000 customers around the world.

Frequently Asked Questions about the Global Digital Genome Market

What is the estimated value of the Global Digital Genome Market?

The Global Digital Genome Market was estimated to be valued at $11024.2 million in 2021.

What is the growth rate of the Global Digital Genome Market?

The growth rate of the Global Digital Genome Market is 9.5%, with an estimated value of $20902.1 million by 2028.

What is the forecasted size of the Global Digital Genome Market?

The Global Digital Genome Market is estimated to be worth $20902.1 million by 2028.

Who are the key companies in the Global Digital Genome Market?

Key companies in the Global Digital Genome Market include Qiagen Nv, Oxford Nanopore Technologies Ltd, Becton, Dickinson, and Company (Bd), Illumina Inc, Thermo Fisher Scientific Inc, Pacific Bioscience, Bio, Rad Laboratories Inc, F. Hoffmann and La Roche.

Report Attribute	Details
No. of Pages	188
Published	February 2021
Forecast Period	2021 - 2028
Estimated Market Value ( USD ) in 2021	$ 11024.2 million
Forecasted Market Value ( USD ) by 2028	$ 20902.1 million
Compound Annual Growth Rate	9.5%
Regions Covered	Global

1. Global Digital Genome Market - Summary

2. Industry Outlook

2.1. Porter's Five Forces Model
2.1.1. Threat of New Entrants
2.1.2. Threat of Substitute Products
2.1.3. Bargaining Power of Buyers
2.1.4. Bargaining Power of Suppliers
2.1.5. Competitive Rivalry
2.2. Impact of Covid-19 on Digital Genome Market
2.3. Market Attractiveness Index
2.4. Vendor Landscape
2.5. Key Insights
2.6. Key Drivers
2.6.1. Proliferating Burden of Chronic Diseases
2.6.2. Continuous Funding by the Manufacturers and Government in the Field of Genomics
2.7. Key Restraints
2.7.1. Security Risks Associated With Digital Genome
2.7.2. Lack of Skilled Professionals in the Field of Genome Technology
2.8. Key Opportunities
2.8.1. Technological Advancements
2.8.2. Prevailing Awareness in the Developing Economies Regarding Dna Sequencing Technologies

3. Digital Genome Market Outlook - by Product

3.1. Sequencing and Analyzer Instruments
3.2. Dna/Rna Analysis
3.3. Sequencing and Analysis Software
3.4. Sequencing Chips
3.5. Sample Prep Instruments

4. Digital Genome Market Outlook - by Application

4.1. Diagnostics
4.2. Drug Discovery
4.3. Academic Research
4.4. Personalized Medicine
4.5. Agricultural
4.6. Other Applications

5. Digital Genome Market Outlook - by End-User

5.1. Diagnostics and Forensic Labs
5.2. Academic Research Institutes
5.3. Hospitals
5.4. Other End-Users

6. Digital Genome Market - Regional Outlook

6.1. North America
6.1.1. Market by Product
6.1.2. Market by Application
6.1.3. Market by End-User
6.1.4. Country Analysis
6.1.4.1. The United States
6.1.4.2. Canada
6.2. Europe
6.2.1. Market by Product
6.2.2. Market by Application
6.2.3. Market by End-User
6.2.4. Country Analysis
6.2.4.1. Germany
6.2.4.2. France
6.2.4.3. The United Kingdom
6.2.4.4. Italy
6.2.4.5. Russia
6.2.4.6. Spain
6.2.4.7. Rest of Europe
6.3. Asia-Pacific
6.3.1. Market by Product
6.3.2. Market by Application
6.3.3. Market by End-User
6.3.4. Country Analysis
6.3.4.1. China
6.3.4.2. Japan
6.3.4.3. Australia & New Zealand
6.3.4.4. India
6.3.4.5. South Korea
6.3.4.6. Asean Countries
6.3.4.7. Rest of Asia-Pacific
6.4. Latin America
6.4.1. Market by Product
6.4.2. Market by Application
6.4.3. Market by End-User
6.4.4. Country Analysis
6.4.4.1. Mexico
6.4.4.2. Brazil
6.4.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.1. Market by Product
6.5.2. Market by Application
6.5.3. Market by End-User
6.5.4. Country Analysis
6.5.4.1. Saudi Arabia
6.5.4.2. United Arab Emirates
6.5.4.3. Turkey
6.5.4.4. South Africa
6.5.4.5. Rest of Middle East & Africa

7. Company Profile

7.1. Qiagen Nv
7.2. Oxford Nanopore Technologies Ltd
7.3. Becton, Dickinson, and Company (Bd)
7.4. Illumina Inc
7.5. Thermo Fisher Scientific Inc
7.6. Pacific Bioscience
7.7. Bio-Rad Laboratories Inc
7.8. F. Hoffmann-La Roche
7.9. Perkinelmer Inc
7.10. Regeneron Pharmaceuticals
7.11. Biomerieux Sa
7.12. Abbott Laboratories
7.13. Agilent Technologies Inc.
7.14. Inscripta

8. Research Methodology & Scope

8.1. Research Scope & Deliverables
8.1.1. Objectives of Study
8.1.2. Scope of Study
8.2. Sources of Data
8.2.1. Primary Data Sources
8.2.2. Secondary Data Sources
8.3. Research Methodology
8.3.1. Evaluation of Proposed Market
8.3.2. Identification of Data Sources
8.3.3. Assessment of Market Determinants
8.3.4. Data Collection
8.3.5. Data Validation & Analysis

List of Tables

Table 1: Global Digital Genome Market, by Region, 2021-2028 (In $ Million)
Table 2: Vendor Landscape
Table 3: Global Digital Genome Market, by Product, 2021-2028 (In $ Million)
Table 4: Global Digital Genome Market, by Application, 2021-2028 (In $ Million)
Table 5: Global Digital Genome Market, by End-User, 2021-2028 (In $ Million)
Table 6: Global Digital Genome Market, by Region, 2021-2028 (In $ Million)
Table 7: North America Digital Genome Market, by Country, 2021-2028 (In $ Million)
Table 8: North America Digital Genome Market, by Product, 2021-2028 (In $ Million)
Table 9: North America Digital Genome Market, by Application, 2021-2028 (In $ Million)
Table 10: North America Digital Genome Market, by End-User, 2021-2028 (In $ Million)
Table 11: Europe Digital Genome Market, by Country, 2021-2028 (In $ Million)
Table 12: Europe Digital Genome Market, by Product, 2021-2028 (In $ Million)
Table 13: Europe Digital Genome Market, by Application, 2021-2028 (In $ Million)
Table 14: Europe Digital Genome Market, by End-User, 2021-2028 (In $ Million)
Table 15: Asia-Pacific Digital Genome Market, by Country, 2021-2028 (In $ Million)
Table 16: Asia-Pacific Digital Genome Market, by Product, 2021-2028 (In $ Million)
Table 17: Asia-Pacific Digital Genome Market, by Application, 2021-2028 (In $ Million)
Table 18: Asia-Pacific Digital Genome Market, by End-User, 2021-2028 (In $ Million)
Table 19: Latin America Digital Genome Market, by Country, 2021-2028 (In $ Million)
Table 20: Latin America Digital Genome Market, by Product, 2021-2028 (In $ Million)
Table 21: Latin America Digital Genome Market, by Application, 2021-2028 (In $ Million)
Table 22: Latin America Digital Genome Market, by End-User, 2021-2028 (In $ Million)
Table 23: Middle East and Africa Digital Genome Market, by Country, 2021-2028 (In $ Million)
Table 24: Middle East and Africa Digital Genome Market, by Product, 2021-2028 (In $ Million)
Table 25: Middle East and Africa Digital Genome Market, by Application, 2021-2028 (In $ Million)
Table 26: Middle East and Africa Digital Genome Market, by End-User, 2021-2028 (In $ Million)

List of Figures

Figure 1: Global Digital Genome Market 2021-2028 (In $ Million)
Figure 2: Global Digital Genome Market, by Sequencing and Analyzer Instruments, 2021-2028 (In $ Million)
Figure 3: Global Digital Genome Market, by Dna/Rna Analysis, 2021-2028 (In $ Million)
Figure 4: Global Digital Genome Market, by Sequencing and Analysis Software, 2021-2028 (In $ Million)
Figure 5: Global Digital Genome Market, by Sequencing Chips, 2021-2028 (In $ Million)
Figure 6: Global Digital Genome Market, by Sample Prep Instruments, 2021-2028 (In $ Million)
Figure 7: Global Digital Genome Market, by Diagnostics, 2021-2028 (In $ Million)
Figure 8: Global Digital Genome Market, by Drug Discovery, 2021-2028 (In $ Million)
Figure 9: Global Digital Genome Market, by Academic Research, 2021-2028 (In $ Million)
Figure 10: Global Digital Genome Market, by Personalized Medicine, 2021-2028 (In $ Million)
Figure 11: Global Digital Genome Market, by Agricultural, 2021-2028 (In $ Million)
Figure 12: Global Digital Genome Market, by Other Applications, 2021-2028 (In $ Million)
Figure 13: Global Digital Genome Market, by Diagnostics and Forensic Labs, 2021-2028 (In $ Million)
Figure 14: Global Digital Genome Market, by Academic Research Institutes, 2021-2028 (In $ Million)
Figure 15: Global Digital Genome Market, by Hospitals, 2021-2028 (In $ Million)
Figure 16: Global Digital Genome Market, by Other End-Users, 2021-2028 (In $ Million)
Figure 17: North America Digital Genome Market 2021-2028 (In $ Million)
Figure 18: the United States Digital Genome Market 2021-2028 (In $ Million)
Figure 19: Canada Digital Genome Market 2021-2028 (In $ Million)
Figure 20: Europe Digital Genome Market 2021-2028 (In $ Million)
Figure 21: Germany Digital Genome Market 2021-2028 (In $ Million)
Figure 22: France Digital Genome Market 2021-2028 (In $ Million)
Figure 23: the United Kingdom Digital Genome Market 2021-2028 (In $ Million)
Figure 24: Italy Digital Genome Market 2021-2028 (In $ Million)
Figure 25: Russia Digital Genome Market 2021-2028 (In $ Million)
Figure 26: Spain Digital Genome Market 2021-2028 (In $ Million)
Figure 27: Rest of Europe Digital Genome Market 2021-2028 (In $ Million)
Figure 28: Asia-Pacific Digital Genome Market 2021-2028 (In $ Million)
Figure 29: China Digital Genome Market 2021-2028 (In $ Million)
Figure 30: Japan Digital Genome Market 2021-2028 (In $ Million)
Figure 31: Australia & New Zealand Digital Genome Market 2021-2028 (In $ Million)
Figure 32: India Digital Genome Market 2021-2028 (In $ Million)
Figure 33: South Korea Digital Genome Market 2021-2028 (In $ Million)
Figure 34: Asean Countries Digital Genome Market 2021-2028 (In $ Million)
Figure 35: Rest of Asia-Pacific Digital Genome Market 2021-2028 (In $ Million)
Figure 36: Latin America Digital Genome Market 2021-2028 (In $ Million)
Figure 37: Mexico Digital Genome Market 2021-2028 (In $ Million)
Figure 38: Brazil Digital Genome Market 2021-2028 (In $ Million)
Figure 39: Rest of Latin America Digital Genome Market 2021-2028 (In $ Million)
Figure 40: Middle East and Africa Digital Genome Market 2021-2028 (In $ Million)
Figure 41: Saudi Arabia Digital Genome Market 2021-2028 (In $ Million)
Figure 42: United Arab Emirates Digital Genome Market 2021-2028 (In $ Million)
Figure 43: Turkey Digital Genome Market 2021-2028 (In $ Million)
Figure 44: South Africa Digital Genome Market 2021-2028 (In $ Million)
Figure 45: Rest of Middle East & Africa Digital Genome Market 2021-2028 (In $ Million)